Efficacy and Safety of Fenfluramine for the Treatment of Seizures Associated With Lennox-Gastaut Syndrome: A Randomized Clinical Trial
NeurologiaSobre o estudo
- Desenho
- Ensaio clínico randomizado
- Nível de evidência
- 2 · Nova evidência
- Revista
- JAMA neurology
- Publicado em
- 1 jun 2022
- Citações
- 0
O resumo deste estudo é do publisher e não tem licença aberta: por isso mostramos aqui só os dados do estudo, e o texto fica na fonte original, nos links abaixo.
O estudo original
Efficacy and Safety of Fenfluramine for the Treatment of Seizures Associated With Lennox-Gastaut Syndrome: A Randomized Clinical Trial
Kelly G Knupp, Ingrid E Scheffer, Berten Ceulemans, Joseph E Sullivan, Katherine C Nickels, Lieven Lagae, Renzo Guerrini, Sameer M Zuberi, Rima Nabbout, Kate Riney et al.
Descritores MeSH
- Lennox Gastaut Syndrome
- Anticonvulsants
- Double-Blind Method
- Fenfluramine
- Adolescent
- Male
- Seizures
- Treatment Outcome
- Humans
Veja também
Estudos relacionados
- Alterações na eficácia e segurança em pacientes com síndrome de Lennox-Gastaut que passam do ensaio controlado randomizado com fenfluramina para o estudo aberto de extensão
- Safety and efficacy of eslicarbazepine acetate for seizure prevention in patients with stroke at high risk of developing post-stroke epilepsy: a proof-of-concept, phase 2a, randomised, double-blind, placebo-controlled antiepileptogenesis trial
- Final analysis from an open-label extension study of fenfluramine for the treatment of seizures in Lennox-Gastaut syndrome: long-term impact on patients and caregivers
- Fenfluramine provides clinically meaningful reduction in frequency of drop seizures in patients with Lennox-Gastaut syndrome: Interim analysis of an open-label extension study